GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (HAM:CLS1) » Definitions » EPS without NRI

McKesson Europe AG (HAM:CLS1) EPS without NRI : €-0.27 (TTM As of Mar. 2022)


View and export this data going back to 2006. Start your Free Trial

What is McKesson Europe AG EPS without NRI?

McKesson Europe AG's earnings per share without non-recurring items for the six months ended in Mar. 2022 was €-0.27. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2022 was €-0.27.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for McKesson Europe AG's EPS without NRI or its related term are showing as below:

HAM:CLS1's 3-Year EPS without NRI Growth Rate is not ranked *
in the Medical Distribution industry.
Industry Median: 5
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

McKesson Europe AG's EPS (Diluted) for the six months ended in Mar. 2022 was €-4.29. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was €-4.29.

McKesson Europe AG's EPS (Basic) for the six months ended in Mar. 2022 was €-4.29. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2022 was €-4.29.


McKesson Europe AG EPS without NRI Historical Data

The historical data trend for McKesson Europe AG's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG EPS without NRI Chart

McKesson Europe AG Annual Data
Trend Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.49 -0.23 -0.35 0.01 -0.27

McKesson Europe AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.49 -0.23 -0.35 0.01 -0.27

Competitive Comparison of McKesson Europe AG's EPS without NRI

For the Medical Distribution subindustry, McKesson Europe AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


McKesson Europe AG's PE Ratio without NRI Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson Europe AG's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where McKesson Europe AG's PE Ratio without NRI falls into.



McKesson Europe AG EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2022 was €-0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


McKesson Europe AG  (HAM:CLS1) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


McKesson Europe AG EPS without NRI Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson Europe AG (HAM:CLS1) Business Description

Traded in Other Exchanges
N/A
Address
Stockholmer Platz 1, Stuttgart, BW, DEU, 70137
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (HAM:CLS1) Headlines

No Headlines